Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02988713 · ClinicalTrials.gov registry record · NA

Study to Characterize Effects of Programming in SCS Patients Undergoing a Temporary Trial

A NA study of Chronic Pain, sponsored by Boston Scientific Corporation.

Completed
Registry status
NA
Development phase
35
Enrollment target
2
Study locations

NCT02988713 is a NA study of Chronic Pain that has completed, run by Boston Scientific Corporation. The registered enrollment target is 35 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02988713, a NA study of Chronic Pain, has completed, sponsored by Boston Scientific Corporation.

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target
2
Study locations

Study Summary

This is a prospective, multi-center, non-randomized, exploratory, single-arm study characterize the effects of programming spinal cord stimulation (SCS) in patients undergoing a Boston Scientific (BSC) spinal cord stimulation (SCS) temporary trial

Conditions Studied

Interventions

  • DEVICE Programming

Study Locations (2)

California

  • Pacific Pain Management, Inc. - Ventura

South Carolina

  • PCPMG Clinical Research Unit, LLC - Greenville

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2016-12-13
Est. Completion 2020-12-02
Phase NA

Sponsor

Boston Scientific Corporation

280 total trials

What the Registry Record Tells You About NCT02988713

The ClinicalTrials.gov registry entry for NCT02988713 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (95% lower). The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which Programming is the first listed.

NCT02988713 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, South Carolina.

Frequently Asked Questions

What is clinical trial NCT02988713 about?

NCT02988713 is a clinical study titled "Study to Characterize Effects of Programming in SCS Patients Undergoing a Temporary Trial". This is a prospective, multi-center, non-randomized, exploratory, single-arm study characterize the effects of programming spinal cord stimulation (SCS) in patients undergoing a Boston Scientific (BSC) spinal cord stimulation (SCS) temporary trial

What is the current status of trial NCT02988713?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2016-12-13. Estimated completion is 2020-12-02.

What conditions does trial NCT02988713 study?

This clinical trial studies the following conditions: Chronic Pain.

What interventions are being tested in trial NCT02988713?

The interventions under investigation include: Programming (DEVICE).

Who is sponsoring clinical trial NCT02988713?

This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02988713 being conducted?

This trial has 2 study locations across California, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.